{
    "1724402835176017926": {
        "attachments": {
            "media_keys": [
                "3_1724402832957153280"
            ]
        },
        "author_id": "5383942",
        "created_at": "2023-11-14T12:24:08.000Z",
        "edit_history_tweet_ids": [
            "1724402835176017926"
        ],
        "entities": {
            "annotations": [
                {
                    "end": 5,
                    "normalized_text": "GSK",
                    "probability": 0.6183,
                    "start": 3,
                    "type": "Organization"
                }
            ],
            "mentions": [
                {
                    "end": 125,
                    "id": "723254289708158976",
                    "start": 115,
                    "username": "GOLD_COPD"
                }
            ],
            "urls": [
                {
                    "display_url": "pic.twitter.com/dWYrCGwZMF",
                    "end": 270,
                    "expanded_url": "https://twitter.com/GSK/status/1724402835176017926/photo/1",
                    "media_key": "3_1724402832957153280",
                    "start": 247,
                    "url": "https://t.co/dWYrCGwZMF"
                }
            ]
        },
        "id": "1724402835176017926",
        "lang": "en",
        "public_metrics": {
            "bookmark_count": 0,
            "impression_count": 3077,
            "like_count": 7,
            "quote_count": 0,
            "reply_count": 1,
            "retweet_count": 1
        },
        "text": "At GSK, we want people to be able to live free from the constraints of respiratory disease. We welcome the updated @GOLD_COPD Strategy for 2024 and will continue to innovate to shape the future so we can get ahead of respiratory disease together. https://t.co/dWYrCGwZMF"
    }
}